Clinical Trial Type: Gastric

Name of this trial: CLARITY-Gastric02 What type of cancer is this for? Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing CLDN 18.2 Who is this trial for? Subjects With Previously Untreated, Locally Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma What biomarkers are involved? Positive expression of Claudin 18.2 What is the National Clinical